terbutaline has been researched along with Pulmonary Fibrosis in 2 studies
Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.
Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, JA | 1 |
| Matthay, RA | 1 |
| Adylova, NA | 1 |
1 review available for terbutaline and Pulmonary Fibrosis
| Article | Year |
|---|---|
Drug-induced pulmonary disease.
Topics: Anti-Arrhythmia Agents; Anticonvulsants; Antineoplastic Agents; Aspirin; Gold; Humans; Hydrochloroth | 1987 |
1 trial available for terbutaline and Pulmonary Fibrosis
| Article | Year |
|---|---|
[Use of a new bronchiolytic preparation terbutaline in the treatment of patients with obstructive lung diseases].
Topics: Adult; Asthma; Bronchitis; Chronic Disease; Clinical Trials as Topic; Drug Evaluation; Female; Human | 1974 |